Fluorouracil 1gm/20ml Inj 20ml

Manufacturer XIROMED Active Ingredient Fluorouracil (Systemic)(flure oh YOOR a sil) Pronunciation FLOOR-oh-YOOR-uh-sil
It is used to treat cancer.
🏷️
Drug Class
Antineoplastic agent
🧬
Pharmacologic Class
Antimetabolite, Pyrimidine analog
🤰
Pregnancy Category
Category D
FDA Approved
Jun 1962
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Fluorouracil is a chemotherapy medicine used to treat various types of cancer. It works by interfering with the growth of cancer cells, causing them to die. It is given as an injection into a vein.
📋

How to Use This Medicine

Taking Your Medication Correctly
To use this medication safely and effectively, follow your doctor's instructions carefully. Read all the information provided to you and adhere to the guidelines.

This medication is administered via injection into a vein, either as a single dose or continuously over a period of time.

Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist to determine the proper storage procedure.

Missing a Dose
If you miss a dose, contact your doctor promptly to receive guidance on the next steps to take.
💡

Lifestyle & Tips

  • Avoid contact with people who are sick or have infections, as this medicine can weaken your immune system.
  • Practice good hand hygiene (frequent hand washing).
  • Report any signs of infection (fever, chills, sore throat) immediately.
  • Maintain good oral hygiene to help prevent mouth sores.
  • Stay well-hydrated and follow dietary recommendations to manage nausea, vomiting, or diarrhea.
  • Avoid excessive sun exposure and use sunscreen, as this medicine can make your skin more sensitive to the sun.
  • Avoid live vaccines during treatment and for a period after, as recommended by your doctor.

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: Highly variable based on indication and regimen (e.g., 400-500 mg/m² IV bolus weekly or 200-300 mg/m²/day continuous IV infusion for colorectal cancer, often with leucovorin).
Dose Range: 200 - 600 mg

Condition-Specific Dosing:

colorectal_cancer: 400-500 mg/m² IV bolus weekly or biweekly; or 200-300 mg/m²/day continuous IV infusion. Often combined with leucovorin.
breast_cancer: 500-600 mg/m² IV on specific days in combination regimens (e.g., CMF regimen).
gastric_pancreatic_cancer: Similar to colorectal cancer regimens, often in combination.
head_and_neck_cancer: Often as a continuous infusion in combination with cisplatin or other agents.
👶

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for general use; used in specific oncology protocols (e.g., some solid tumors, CNS tumors) with highly individualized dosing based on protocol.
Adolescent: Not established for general use; used in specific oncology protocols with highly individualized dosing based on protocol.
⚕️

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment generally required.
Moderate: No specific dose adjustment generally required, but monitor for increased toxicity.
Severe: Use with caution; consider dose reduction or extended dosing intervals, monitor closely for toxicity. No clear guidelines for specific adjustments.
Dialysis: Fluorouracil is dialyzable. Administer after dialysis. Monitor for increased toxicity.

Hepatic Impairment:

Mild: Use with caution; monitor for increased toxicity.
Moderate: Use with caution; consider dose reduction (e.g., 30-50%) and monitor closely for toxicity. No clear guidelines for specific adjustments.
Severe: Contraindicated or use with extreme caution; significant dose reduction likely required. Monitor closely for toxicity.

Pharmacology

🔬

Mechanism of Action

Fluorouracil (5-FU) is a pyrimidine analog antimetabolite. It is converted intracellularly to several active metabolites, including fluorodeoxyuridine monophosphate (FdUMP), fluorouridine triphosphate (FUTP), and fluorodeoxyuridine triphosphate (FdUTP). FdUMP inhibits thymidylate synthase, an enzyme critical for DNA synthesis, thereby blocking the methylation of deoxyuridylic acid to thymidylic acid. FUTP is incorporated into RNA, leading to dysfunctional RNA. FdUTP is incorporated into DNA, leading to DNA damage and inhibition of DNA synthesis and function. These actions ultimately lead to cell death, particularly in rapidly dividing cells.
📊

Pharmacokinetics

Absorption:

Bioavailability: 100% (IV administration)
Tmax: Not applicable (IV bolus: peak concentration immediately after administration; continuous infusion: steady-state reached over time)
FoodEffect: Not applicable (IV administration)

Distribution:

Vd: Approximately 0.12 L/kg
ProteinBinding: <10%
CnssPenetration: Limited, but detectable levels in CSF; higher with continuous infusion than bolus.

Elimination:

HalfLife: Biphasic: Initial half-life ~6-20 minutes; terminal half-life is longer but still short, typically 10-20 minutes.
Clearance: Rapid, highly variable due to DPD activity.
ExcretionRoute: Mainly metabolic degradation (60-80%); 10-20% excreted unchanged in urine.
Unchanged: 10-20%
⏱️

Pharmacodynamics

OnsetOfAction: Rapid (within minutes of administration)
PeakEffect: Dependent on regimen; cellular effects occur rapidly after uptake and metabolism.
DurationOfAction: Short plasma half-life, but cellular effects persist longer due to intracellular metabolism and incorporation into nucleic acids.

Safety & Warnings

⚠️

BLACK BOX WARNING

Fluorouracil is associated with significant toxicities, including myelosuppression (leukopenia, thrombocytopenia, anemia), mucositis (stomatitis, esophagitis, enteritis, diarrhea), and hand-foot syndrome. Severe and sometimes fatal toxicities have occurred, particularly in patients with dihydropyrimidine dehydrogenase (DPD) deficiency. Monitor patients closely for signs of toxicity and manage appropriately. Discontinue therapy if severe toxicity occurs.
⚠️

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of nervous system problems, including:
+ Changes in mood or behavior
+ Confusion
+ Fever
+ Numbness or tingling in the hands or feet
+ Stiff neck
+ Sensitivity to bright lights
+ Severe muscle weakness
Signs of infection, such as:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or discolored sputum
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of bleeding, including:
+ Vomiting or coughing up blood
+ Coffee ground-like vomit
+ Blood in the urine
+ Black, red, or tarry stools
+ Gum bleeding
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruising that worsens
+ Uncontrollable bleeding
Feeling extremely tired or weak
Chest pain or pressure
Shortness of breath, significant weight gain, or swelling in the arms or legs
Abnormal heartbeat
Dizziness or fainting
Changes in vision
Redness or irritation on the palms of the hands or soles of the feet
Balance problems
Excessive sleepiness
Uncontrolled eye movements
Headache

If you experience any of these symptoms, notify your doctor or seek medical attention immediately.

Administration Site Reactions

This medication may cause irritation at the injection site. If the medication leaks from the vein, it can also cause irritation around the affected area. Inform your nurse if you experience any redness, burning, pain, swelling, or fluid leakage at the injection site.

Other Possible Side Effects

Like all medications, this drug can cause side effects. However, many people may not experience any side effects or may only have mild ones. If you notice any of the following side effects or any other symptoms that bother you or persist, contact your doctor:

Diarrhea
Upset stomach or vomiting
Decreased appetite
Mouth irritation or mouth sores
Hair loss
Dry skin
Changes in nail condition

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Fever (100.4°F or higher) or chills
  • Severe diarrhea (more than 4-6 loose stools per day)
  • Severe mouth sores or pain in the mouth/throat
  • Unusual bleeding or bruising
  • Extreme fatigue or weakness
  • Redness, swelling, pain, or peeling of the palms of hands or soles of feet (hand-foot syndrome)
  • Chest pain or shortness of breath
  • Signs of allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms.
Certain health conditions, such as:
+ Poor nutrition
+ Infections
+ Bone marrow problems, including low white blood cell count, low platelet count, or low red blood cell count
+ Dihydropyrimidine dehydrogenase (DPD) deficiency
* If you are breastfeeding, as you should not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests and other laboratory evaluations, as directed by your doctor, are crucial to monitor your condition.

This medication can cause low blood cell counts, which may lead to bleeding problems, infections, or anemia. In severe cases, these complications can be life-threatening. If you have any questions or concerns, discuss them with your doctor. You may be more susceptible to infections, so it is vital to practice good hygiene by washing your hands frequently and avoiding close contact with people who have infections, colds, or flu.

Bleeding can occur more easily while taking this medication, so it is crucial to be cautious and avoid injuries. To minimize the risk of bleeding, use a soft toothbrush and an electric razor. If you experience stomach upset, vomiting, diarrhea, or loss of appetite, consult your doctor, as there may be ways to reduce these side effects. If you have diarrhea or vomiting, it is essential to discuss this with your doctor to prevent dehydration and electrolyte imbalances.

Patients who lack the enzyme dihydropyrimidine dehydrogenase (DPD) are at a higher risk of developing severe and potentially life-threatening side effects, including mouth irritation or sores, diarrhea, low white blood cell counts, and nerve problems.

This medication may increase the risk of heart problems, such as heart attack, heart failure, and abnormal heartbeat, particularly in individuals with a history of heart disease. Discuss your cardiovascular health with your doctor. Before receiving any vaccinations, consult your doctor, as some vaccines may not be effective or may increase the risk of infection when taken with this medication.

You may be more prone to sunburn while taking this medication, so take necessary precautions when exposed to the sun. If you experience increased sensitivity to the sun, inform your doctor. This medication may also affect fertility, leading to difficulties in becoming pregnant or fathering a child. If you plan to conceive, discuss this with your doctor before starting treatment.

If you are pregnant or plan to become pregnant, it is essential to note that this medication may harm the unborn baby. If you or your partner may become pregnant, you must use effective birth control during treatment and for a specified period after the last dose. Your doctor will advise you on the duration of birth control use. If you or your partner becomes pregnant, notify your doctor immediately.
🆘

Overdose Information

Overdose Symptoms:

  • Exacerbated myelosuppression (severe leukopenia, thrombocytopenia)
  • Severe mucositis/stomatitis
  • Severe diarrhea
  • Gastrointestinal hemorrhage
  • Neurotoxicity (ataxia, confusion, seizures)

What to Do:

There is no specific antidote for fluorouracil overdose. Management is supportive, including aggressive hydration, antiemetics, antidiarrheals, antibiotics for neutropenic fever, and potentially uridine triacetate (Vistogard) for early-onset, severe, or life-threatening toxicity or overdose. Call 1-800-222-1222 (Poison Control Center) for immediate guidance.

Drug Interactions

🚫

Contraindicated Interactions

  • Live vaccines (due to immunosuppression)
🔴

Major Interactions

  • Leucovorin (enhances fluorouracil's cytotoxic effects and toxicity, particularly gastrointestinal and hematologic)
  • Allopurinol (may decrease fluorouracil's efficacy by interfering with its activation)
  • Cimetidine (may increase fluorouracil levels and toxicity)
  • Metronidazole (may increase fluorouracil levels and toxicity)
  • Warfarin (may increase INR and risk of bleeding)
  • Thiazide diuretics (may increase myelosuppression)
  • Phenytoin (may increase phenytoin levels and toxicity)
🟡

Moderate Interactions

  • Other myelosuppressive agents (additive myelosuppression)
  • Drugs causing QT prolongation (potential additive effect)
  • Folinic acid (leucovorin) - while often co-administered, it significantly modifies 5-FU's toxicity profile, requiring careful dosing and monitoring.
  • Tamoxifen (may increase risk of thromboembolic events)
🟢

Minor Interactions

  • Not available

Monitoring

🔬

Baseline Monitoring

Complete Blood Count (CBC) with differential and platelets

Rationale: To assess baseline hematopoietic function before starting myelosuppressive therapy.

Timing: Prior to initiation of therapy.

Liver Function Tests (LFTs)

Rationale: To assess baseline hepatic function, as fluorouracil is primarily metabolized in the liver.

Timing: Prior to initiation of therapy.

Renal Function Tests (Creatinine, BUN)

Rationale: To assess baseline renal function, as a portion of fluorouracil is renally excreted.

Timing: Prior to initiation of therapy.

Dihydropyrimidine Dehydrogenase (DPD) deficiency testing

Rationale: To identify patients at high risk for severe and potentially fatal toxicity due to impaired fluorouracil metabolism. Recommended by some guidelines, especially for continuous infusion or high-dose regimens.

Timing: Consider prior to initiation of therapy, particularly for patients with a history of severe toxicity or those receiving continuous infusion.

📊

Routine Monitoring

Complete Blood Count (CBC) with differential and platelets

Frequency: Weekly or prior to each dose/cycle, and as clinically indicated.

Target: Maintain ANC >1500 cells/mm³ and platelets >100,000 cells/mm³ (may vary by protocol).

Action Threshold: Hold or reduce dose for significant myelosuppression (e.g., ANC <1000 cells/mm³, platelets <50,000 cells/mm³).

Liver Function Tests (LFTs)

Frequency: Periodically, or as clinically indicated.

Target: Within normal limits or stable.

Action Threshold: Significant elevation may require dose modification or discontinuation.

Renal Function Tests (Creatinine, BUN)

Frequency: Periodically, or as clinically indicated.

Target: Within normal limits or stable.

Action Threshold: Significant impairment may require dose modification.

Electrolytes (especially potassium, magnesium, calcium)

Frequency: As clinically indicated, especially with significant diarrhea or vomiting.

Target: Within normal limits.

Action Threshold: Correct imbalances promptly.

👁️

Symptom Monitoring

  • Signs of myelosuppression (fever, chills, sore throat, unusual bleeding/bruising, fatigue)
  • Gastrointestinal toxicity (severe diarrhea, mucositis/stomatitis, nausea, vomiting, abdominal pain)
  • Dermatologic reactions (hand-foot syndrome/palmar-plantar erythrodysesthesia, rash, nail changes)
  • Neurological symptoms (ataxia, confusion, lethargy, headache, visual disturbances)
  • Cardiotoxicity (chest pain, dyspnea, ECG changes)
  • Signs of infection

Special Patient Groups

🤰

Pregnancy

Fluorouracil is classified as Pregnancy Category D. It can cause fetal harm when administered to a pregnant woman. It is teratogenic and embryotoxic in animals. Avoid use during pregnancy.

Trimester-Specific Risks:

First Trimester: High risk of major congenital malformations and fetal death due to rapid cell division and organogenesis.
Second Trimester: Risk of fetal growth restriction, myelosuppression, and other adverse effects.
Third Trimester: Risk of fetal growth restriction, myelosuppression, and other adverse effects; potential for premature labor.
🤱

Lactation

Fluorouracil is contraindicated during breastfeeding (Lactation Risk L5). It is unknown if fluorouracil is excreted in human milk, but due to its potential for serious adverse reactions in breastfed infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: High risk of serious adverse effects, including myelosuppression, growth inhibition, and other toxicities.
👶

Pediatric Use

Safety and effectiveness in pediatric patients have not been established for all indications. Use in pediatric oncology is limited to specific protocols where the benefits outweigh the risks. Dosing is highly individualized and requires careful monitoring.

👴

Geriatric Use

Elderly patients may be at increased risk for fluorouracil-related toxicities, particularly myelosuppression, mucositis, and diarrhea. Close monitoring of hematologic parameters and gastrointestinal symptoms is essential. Dose adjustments may be necessary based on tolerance and renal/hepatic function.

Clinical Information

💎

Clinical Pearls

  • DPD (dihydropyrimidine dehydrogenase) deficiency is a critical pharmacogenomic factor; patients with partial or complete DPD deficiency are at significantly increased risk of severe, life-threatening, or fatal fluorouracil toxicity. Consider DPD testing, especially for continuous infusion regimens or if severe early toxicity occurs.
  • Hand-foot syndrome (palmar-plantar erythrodysesthesia) is a common and often dose-limiting toxicity, particularly with continuous infusion. Management includes dose reduction, topical emollients, and sometimes pyridoxine.
  • Mucositis and diarrhea are common and can be severe. Aggressive supportive care, including antiemetics, antidiarrheals, and oral hygiene, is crucial.
  • Cardiotoxicity, though rare, can occur (e.g., angina, ECG changes, myocardial infarction), especially in patients with pre-existing cardiac disease. Monitor for cardiac symptoms.
  • Neurological toxicities (e.g., ataxia, confusion) are less common but can occur, particularly with high doses or prolonged infusions.
  • Leucovorin (folinic acid) is often co-administered with fluorouracil to enhance its cytotoxic effects, but it also increases toxicity, requiring careful dose titration and monitoring.
🔄

Alternative Therapies

  • Other antimetabolites (e.g., Gemcitabine, Pemetrexed, Methotrexate)
  • Platinum-based agents (e.g., Oxaliplatin, Cisplatin, Carboplatin)
  • Taxanes (e.g., Paclitaxel, Docetaxel)
  • Targeted therapies (e.g., EGFR inhibitors, VEGF inhibitors, BRAF inhibitors, depending on cancer type)
  • Immunotherapy (e.g., PD-1/PD-L1 inhibitors, depending on cancer type)
💰

Cost & Coverage

Average Cost: Varies widely by dose, formulation, and supplier. Typically ranges from $50-$200+ per 1gm/20ml vial. per 1gm/20ml vial
Generic Available: Yes
Insurance Coverage: Generally covered by most medical and pharmacy benefit plans as a Tier 3 or specialty drug, often requiring prior authorization due to its use in cancer therapy.
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance.

To ensure safe use, do not share your medication with others, and never take someone else's medication. Store all medications in a secure location, out of reach of children and pets, to prevent accidental ingestion.

Proper disposal of unused or expired medications is crucial. Do not flush medications down the toilet or pour them down the drain unless specifically instructed to do so by a healthcare professional or pharmacist. If you are unsure about the best method for disposing of medications, consult with your pharmacist, who can provide guidance on safe disposal practices. Additionally, you may want to inquire about potential drug take-back programs in your area.

Some medications may have additional patient information leaflets available. Your pharmacist can provide more information on this. If you have any questions or concerns about your medication, it is recommended that you discuss them with your doctor, nurse, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide critical information, including the name of the medication taken, the amount, and the time it was taken, to ensure prompt and effective treatment.